zum Originalbeitrag

Issuer: Springer Nature AG & Co KGaA (“Springer Nature”)

Company Description: Springer Nature is a leading global academic, education and professional publisher operating in more than 120 markets, dedicated to advancing discovery and learning.

Joint Global Coordinators: J.P. Morgan and Morgan Stanley

Joint Bookrunners: Goldman Sachs International, BNP Paribas, Bank of America Merrill Lynch, Credit Suisse, Société Générale CIB

Offering Type: Initial public offering of ordinary primary and secondary shares

Selling Shareholder: BC Partners (TBD subject to market conditions)

Key Shareholders: Holtzbrinck Publishing Group (HPG) (53% shareholder pre-IPO, will not sell any shares and is committed to remaining a long-term shareholder)
BC Partners (47% shareholder pre-IPO)

Offering Size: €1.2bn Primary
Secondary TBD

Offering Currency: EUR

Use of Proceeds: To strengthen Springer Nature’s financial profile. The net leverage ratio will fall to 3.5x 2017 adjusted EBITDA at IPO.

Distribution: Offers (i) to Qualified Institutional Buyers in the United States pursuant to Rule 144A; and (ii) outside the United States in accordance with Regulation S
Public offer in Germany and Luxembourg and private placements in certain jurisdictions outside Germany and Luxembourg

MIFID II Target market: Manufacturer target market (MIFID II product governance) is retail investors, eligible counterparties and professional clients (all distribution channels)

Lock-up: TBD

Greenshoe: TBD

Price Range: TBD

Expected Pricing Date: TBD

Expected Start of Trading: TBD

Expected Settlement Date: TBD

Listing: Regulated market (Prime Standard) of the Frankfurt Stock Exchange

Ticker: TBD


Beitrag dem Admin melden | Urheberrechtsverletzung melden

Thema #7667
 Erstes Thema | Letztes Thema

Powered by DCForum+ Version 1.27
Copyright 1997-2003 DCScripts.com